Cargando…
Dipeptidyl peptidase 4 inhibitor improves insulin resistance in Japanese patients with type 2 diabetes: a single-arm study, a brief report
BACKGROUND: Dipeptidyl peptidase 4 inhibitor (DPP4i) is an effective medicine for type 2 diabetes mellitus (T2DM). Some articles reported DPP4i improves insulin secretion and insulin resistance. However, these effects are not well established by glucose clamp test and test meal in Japanese. We inves...
Autores principales: | Okura, Tsuyoshi, Fujioka, Yohei, Nakamura, Risa, Ito, Yuichi, Kitao, Sonoko, Anno, Mari, Matsumoto, Kazuhisa, Shoji, Kyoko, Okura, Hiroko, Matsuzawa, Kazuhiko, Izawa, Shoichiro, Ueta, Etsuko, Kato, Masahiko, Imamura, Takeshi, Taniguchi, Shin-ichi, Yamamoto, Kazuhiro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9171964/ https://www.ncbi.nlm.nih.gov/pubmed/35672759 http://dx.doi.org/10.1186/s13098-022-00850-9 |
Ejemplares similares
-
The sodium–glucose cotransporter 2 inhibitor ipragliflozin improves liver function and insulin resistance in Japanese patients with type 2 diabetes
por: Okura, Tsuyoshi, et al.
Publicado: (2022) -
Hepatic insulin clearance is increased in patients with high HbA1c type 2 diabetes: a preliminary report
por: Okura, Tsuyoshi, et al.
Publicado: (2020) -
Significance of pancreatic duodenal homeobox-1 (PDX-1) genetic polymorphism in insulin secretion in Japanese patients with type 2 diabetes
por: Okura, Tsuyoshi, et al.
Publicado: (2022) -
Aldehyde dehydrogenase 2 polymorphism is an important gene for insulin resistance in Japanese patients with type 2 diabetes
por: Okura, Tsuyoshi, et al.
Publicado: (2023) -
Body mass index ≥23 is a risk factor for insulin resistance and diabetes in Japanese people: A brief report
por: Okura, Tsuyoshi, et al.
Publicado: (2018)